uniQure (QURE) Receivables (2015 - 2026)
uniQure's (QURE) quarterly Receivables came in at $3.6 million in Q1 2026, up 41.24% year-on-year from $2.5 million in Q1 2025, and down 39.25% quarter-over-quarter from $5.9 million in Q4 2025.
uniQure (QURE) Receivables (2015 - 2026) Analysis & Trends
uniQure's Receivables history runs 10 years deep, the most recent figure standing at $3.6 million for Q1 2026.
- On a quarterly basis, Receivables rose 41.24% year-over-year to $3.6 million in Q1 2026; TTM through Mar 2026 was $3.6 million, a 41.24% increase from a year earlier, with the FY2025 full-year figure at $5.9 million, changed 0.32% from the prior year.
- Receivables slipped to $3.6 million in Q1 2026 per QURE's latest filing, from $5.9 million in the prior quarter.
- Across five years, Receivables topped out at $204.8 million in Q1 2023 and bottomed at $1.6 million in Q3 2023.
- The 5-year median for Receivables is $5.7 million (2024), against an average of $36.4 million.
- Across the five-year window, Receivables surged 2048.58% in 2022 and slumped 96.01% in 2023, its largest moves.
- Year by year, Receivables stood at $100.1 million in 2022, then slumped by 96.01% to $4.0 million in 2023, then jumped by 42.5% to $5.7 million in 2024, then advanced by 2.86% to $5.9 million in 2025, then sank by 39.25% to $3.6 million in 2026.
- Per Business Quant, the three latest QURE Receivables figures stand at $3.6 million (Q1 2026), $5.9 million (Q4 2025), and $3.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn | 3.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.56 Mn |
| Dec 31, 2025 | 5.86 Mn |
| Sep 30, 2025 | 3.88 Mn |
| Jun 30, 2025 | 5.61 Mn |
| Mar 31, 2025 | 2.52 Mn |
| Dec 31, 2024 | 5.70 Mn |
| Sep 30, 2024 | 5.32 Mn |
| Jun 30, 2024 | 7.85 Mn |
| Mar 31, 2024 | 10.72 Mn |
| Dec 31, 2023 | 4.00 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Jun 30, 2023 | 102.56 Mn |
| Mar 31, 2023 | 204.79 Mn |
| Dec 31, 2022 | 100.14 Mn |
| Sep 30, 2022 | 3.60 Mn |
| Jun 30, 2022 | 58.12 Mn |
| Mar 31, 2022 | 93.64 Mn |
| Dec 31, 2021 | 57.90 Mn |
| Sep 30, 2021 | 3.77 Mn |
| Jun 30, 2021 | 2.71 Mn |